MedInfo AI Cuts Promotion Costs by 70% with 'AI + Compliance' to Build a New Academic Ecosystem in Healthcare

In recent years, under the dual waves of anti-corruption in the pharmaceutical sector and digital transformation, China's healthcare industry is undergoing profound changes.

On one hand, the anti-corruption campaign in the pharmaceutical sector continues to maintain high-pressure intensity. In June this year, the medical rectification initiative was officially launched, with 14 ministries and commissions jointly promoting penetrative supervision to achieve comprehensive coverage across all links of the healthcare system. On the other hand, the digital transformation of healthcare is accelerating. Data from China Business Industry Research Institute shows that the market size of China’s integrated digital health services exceeded RMB 220 billion in 2024, with new technologies such as AI deeply empowering the entire pharmaceutical industry chain.

In this context, Medinfo Intelligence Technology (Hangzhou) Co., Ltd. (hereinafter referred to as “Medinfo Intelligence”) has targeted this market trend and made a precise entry into the “Empowering Physicians + Compliant Promotion by Pharmaceutical Companies“In this vertical sector, powered by the dual engines of AI and compliance, we connect the key needs of physicians, pharmaceutical companies, and healthcare institutions to build a trusted, efficient, and fully compliant digital academic center and service platform.”

The establishment of MEDINFO INTELLIGENCE stems from the core team’s deep insights into the pain points across the entire healthcare industry chain, which clarified the company’s core value proposition. Founder Ye Chunzheng brings eight years of experience as a clinician and has previously served as a pharmaceutical sales representative, sales manager, general manager of a manufacturing enterprise, and national distributor. He has personally witnessed the efficiency bottlenecks and compliance anxieties inherent in medical service delivery and promotion. The team’s multifaceted experience spanning clinical practice, promotion, and industry provides a more comprehensive understanding of the healthcare sector.

From the physician’s perspective, the medical community faces common challenges. Amidst a saturated workload, physicians lack the time for systematic learning and are limited to attending “check-in” style conferences or passively receiving fragmented academic information. In reality, first, long-term clinical work makes it difficult for many physicians to devote energy to scientific research; second, gaps in patient information during cross-hospital diagnosis and treatment further exacerbate the difficulties of patient management. Meanwhile, there is a lack of compliant and transparent mechanisms for remunerating physicians’ professional output, failing to create a closed loop for the value of their knowledge.

On the industry front, the pharmaceutical sector faces pressure to transform under stringent regulation. While foreign pharmaceutical companies adhere to the RDPAC Code (the Code of Conduct for the Pharmaceutical Industry established by the R&D Committee of the China Association of Enterprises with Foreign Investment), there is no unified standard domestically. The traditional promotion model, which relies heavily on interpersonal connections, is not only costly but also poses increasingly prominent compliance risks.

These “pain points” became the “starting point” for the founding of MEDINFO INTELLIGENCE. Instead of building another “large and comprehensive” medical community, it started with the mission: “We aim to be a digital assistant for physicians, helping them save time and enhance their capabilities; and to serve as a compliant channel for pharmaceutical companies, helping them reduce costs, control risks, and facilitate academic outreach.” This vision ultimately materialized into the MEDINFO INTELLIGENCE platform, which focuses on compliant academic promotion and fills a gap in the industry.

Schematic Diagram of the Dual-End Model of MEDINFO INTELLIGENCE Source: MEDINFO INTELLIGENCE

Against the backdrop of normalized anti-corruption efforts in the healthcare sector, compliance is the lifeline for a platform’s survival and development. Since its inception, MEDINFO INTELLIGENCE has integrated compliance throughout its entire operational process, proclaiming “Compliance First, No Excuses” slogan, through “No Drug Sales, Regulatory Compliance, Strengthened Oversight” triple-layered system, building a safety barrier for physicians and pharmaceutical companies.

The interview explicitly stated that the platform strictly refrains from engaging in drug sales and prescription processes—it does not require physicians to prescribe specific medications in exchange for rewards, nor does it guide patients to purchase drugs. All services are centered on “academic resource integration” and are completely decoupled from drug sales volume. This de-commercialized positioning eliminates conflicts of interest at their source and distinguishes the platform from the profit-driven, drug-centric model adopted by most third-party medical platforms.

Meanwhile, the platform strictly aligns with national healthcare regulations and policies issued by health authorities, using the requirements of “Healthy China 2030” and detailed anti-corruption measures in the medical sector as core benchmarks to ensure that all services comply with local regulatory requirements. At a granular level, it simultaneously adheres to the compliance guidelines established by RDPAC—one of the most authoritative international frameworks for academic promotion in the pharmaceutical industry—thereby ensuring that promotional activities are both compliant and globally oriented.

Furthermore, to ensure data security and regulatory compliance, MEDINFO INTELLIGENCE stores data on the regulated Alibaba Cloud platform. All operations are logged and traceable, eliminating the risk of unauthorized actions. This ensures that every interaction is transparent and trustworthy, providing greater peace of mind for physicians and pharmaceutical companies using the platform.

This compliance, spanning from top-level design to detailed implementation, makes the platform a trusted choice for pharmaceutical companies and physicians.

Unlike the broad positioning of comprehensive medical knowledge communities such as DXY, MEDINFO INTELLIGENCE is a SaaS platform that provides vertical empowerment to physicians and pharmaceutical companies.

The platform serves as both an academic assistant for physicians and a patient management tool, as well as a compliant promotional channel for pharmaceutical companies. Its technological core relies on proprietary AI algorithms and big data computing power, completely replacing the traditional human-centric promotion model to achieveFull-process traceability, full-content compliance, and full-link visualization, thereby establishing a differentiated competitive barrier against comprehensive platforms.

Overview of MEDINFO INTELLIGENCE Service Solutions From: MEDINFO INTELLIGENCE

Medical Services: From Free Guideline Searches to Live Streaming, Solving Doctors’ “Academic Time Crunch”

The Medical Services Module is an academic growth engine crafted by MEDINFO INTELLIGENCE for physicians, addressing pain points such as fragmented information access, limited time, and high barriers to professional output through content deconstruction and compliant operations.

● Clinical Guidelines and Consensus: Directly connects to authoritative sources such as the official website of the National Health Commission and medical associations, enabling real-time synchronization and structured classification of clinical guidelines. Physicians can access these resources free of charge and rapidly, replacing the paid models of traditional third-party platforms and ensuring the authority and timeliness of diagnostic and therapeutic evidence.

● Academic Center: Operated by a team of medical and pharmaceutical master’s and doctoral degree holders born after 1995, this team did not experience the period of unregulated growth in the pharmaceutical industry and possesses an inherent understanding of compliance. They deconstruct content algorithms to transform complex academic materials and pharmaceutical company information into lightweight formats such as three-minute short videos and graphic-text summaries, catering to doctors’ fragmented schedules and enabling efficient knowledge acquisition.

● MEDINFO Live: Provides "full-managed" operational support spanning initial planning, mid-stage production, post-event promotion, and retrospective analysis, allowing physicians to focus solely on content creation. The entire live-streaming process is documented to ensure compliance, auditability, and traceability, thereby alleviating compliance concerns for both medical institutions and physicians. The service covers multiple scenarios, including patient education, academic exchange, and continuing medical education. Since its launch in June 2025, the platform has hosted 45 physician-led live streams, partnered with multiple community health service centers across Zhejiang Province, and cultivated high-value physician intellectual property (IP).

AI Cloud Promotion: The Digital Closed-Loop for Compliant Pharmaceutical Marketing

AI-driven cloud-based academic promotion focuses on addressing the key pain points in pharmaceutical companies’ promotional efforts, achieving a revolutionary improvement in promotional efficiency through a digital closed-loop system featuring precise targeting, compliant engagement, and intelligent optimization.

First, inPrecise TargetingIn this phase, the platform leverages multi-dimensional data tagging algorithms to construct comprehensive physician profiles by integrating physicians’ basic attributes and behavioral preferences. For instance, it tags community general practitioners as focusing on chronic disease management, while labeling neurologists at tertiary Grade A hospitals as interested in cutting-edge surgical protocols, thereby avoiding the resource waste associated with traditional broad-brush marketing approaches.

Secondly,Compliant EngagementThis phase leverages diversified content conversion tools and time-slot matching algorithms to deconstruct pharmaceutical company information into various formats, including articles, short videos, audio clips, and interactive questionnaires. All exaggerated claims are filtered out, and algorithms analyze physicians' available time slots to deliver precise mobile push notifications, with a complete audit trail maintained for all interactions.

Finally,Intelligent OptimizationBy leveraging a real-time dashboard of over 540,000 terminal data points and behavioral analytics algorithms, this module automatically analyzes physicians’ behavioral data, feeds insights back to the marketing department, and guides subsequent adjustments to academic engagement strategies.

Data provided by the company shows that this closed-loop system has not only increased the number of physicians served per academic support staff member from 50 to 1,000—a 20-fold expansion in service coverage—but also reduced monthly costs from an average of RMB 1 million to RMB 300,000, representing a 70% decrease. Furthermore, academic services have been transformed from “offline messengers” into “digital operations officers.”

Private Domain Services: Direct Patient Reach and Management

Within the context of MEDINFO INTELLIGENCE, “private domain” is redefined as a digital academic and patient service platform that physicians can operate autonomously in a compliant and trustworthy manner. It is not a traditional traffic-generating arena, but rather a core digital asset for physicians to build their personal professional brands, cultivate patient relationships, and realize service value.

Through the exclusive QR code generated by the platform, physicians can bind patients with a single click. The system then automatically synchronizes medical records, medication cycles, and disease tags, and sends follow-up visit and medication reminders based on preset rules, thereby forming an intelligent closed-loop patient management system.

The concurrently established GIGA Mall and Health Bean system create a compliant channel for converting knowledge into value. Physicians earn Health Beans by participating in academic activities and producing popular science content, which can be redeemed for products or points. This fosters a virtuous cycle of knowledge dissemination and compliant incentives, enhancing physician engagement while promoting the widespread adoption of medical literacy.

Based on an in-depth analysis of industry trends, MEDINFO INTELLIGENCE has established a clear strategic path: deepening its focus on medical digitalization in the Chinese market while simultaneously exploring bidirectional connectivity with overseas resources, thereby creating growth opportunities in niche segments through differentiated positioning.

Currently, the platform has accumulated over 10,000 physician users in Zhejiang Province, establishing a regional model that lays the foundation for nationwide expansion. In the next phase, MEDINFO INTELLIGENCE will systematically cover all district and county hospitals and community health service centers in Zhejiang, and gradually replicate this model in medical hubs such as Shanghai and Guangzhou, thereby upgrading its regional tool into a national platform.

Furthermore, Ye Chuncheng emphasized that “the core growth drivers lie at the grassroots level.” With the deepening of the national “three-tier diagnosis and treatment” policy and the decentralization of medical resources, demand for digital solutions in primary healthcare continues to grow. MEDINFO INTELLIGENCE will focus on optimizing scenario-based platform functionalities and services, addressing the pain points of limited tool availability and weak research capabilities among grassroots physicians.

While deepening its services, MEDINFO INTELLIGENCE is committed to building a localized compliance promotion standard system in China, promoting the establishment of promotional guidelines similar to the international RDPAC Code, so that academic promotion can be “guided by clear rules and supported by solid evidence,” thereby providing infrastructure for the compliant development of the industry.

In terms of its international strategy, the platform adopts a two-pronged approach: on one hand, leveraging Hong Kong’s international advantages to explore localized models for medical information services; on the other, actively integrating big health resources from overseas markets such as Japan, with plans to introduce chronic disease management tools and health products not yet widely available in China, thereby achieving synergy between the global expansion of its technological model and the introduction of high-quality external resources.

The establishment of MEDINFO INTELLIGENCE reflects a microcosm of the development of China's healthcare industry.

If DXY has addressed the pain point of information asymmetry in healthcare, then MEDINFO INTELLIGENCE seeks to resolve issues of trust and efficiency driven by the dual forces of stringent regulation and digitalization. By pursuing a “narrow but deep” strategy and leveraging the dual engines of AI and compliance, it has carved out a distinct niche for itself in an apparently crowded market, establishing a space for survival and growth defined by rigid demand and significant barriers to entry.

As compliance and digitalization deepen within the healthcare industry, MEDINFO INTELLIGENCE, a platform focused on being “small yet specialized,” is leveraging practical technologies and services to drive smart healthcare into grassroots settings, benefiting both doctors and patients, and gradually emerging as a significant force in optimizing the medical academic ecosystem.